research Telogen Effluvium due to Recombinant Interferon α-2b
Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.
Delhi, Delhi, India
Brescia, Italy
Jaipur, Rajasthan, India
Nizāmābād, Telangana, India
Coimbatore, Tamil Nadu, India
Uppal Kalan, Telangana, India


